Atrium Therapeutics, Inc. - RNA
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 18
Latest filed: May 15, 2026
| Form | Count |
|---|---|
| 4 | 11 |
| 8-K | 5 |
| SCHEDULE 13G | 2 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G | — | 0001346824-26-000145 | View |
| May 14, 2026 | 8-K | May 14, 2026 | 0001193125-26-224238 | View |
| Apr 22, 2026 | 4 | Apr 20, 2026 | 0001193125-26-170964 | View |
| Apr 22, 2026 | 4 | Apr 20, 2026 | 0001193125-26-170963 | View |
| Apr 22, 2026 | 4 | Apr 20, 2026 | 0001193125-26-170960 | View |
| Apr 22, 2026 | 4 | Apr 20, 2026 | 0001193125-26-170914 | View |
| Apr 22, 2026 | 4 | Apr 20, 2026 | 0001193125-26-170907 | View |
| Apr 22, 2026 | 4 | Apr 20, 2026 | 0001193125-26-170906 | View |
| Apr 08, 2026 | SCHEDULE 13G | — | 0000080255-26-000316 | View |
| Mar 02, 2026 | 4 | Feb 27, 2026 | 0001193125-26-085922 | View |
| Mar 02, 2026 | 4 | Feb 27, 2026 | 0001193125-26-085921 | View |
| Mar 02, 2026 | 4 | Feb 27, 2026 | 0001193125-26-085920 | View |
| Mar 02, 2026 | 4 | Feb 27, 2026 | 0001193125-26-085919 | View |
| Mar 02, 2026 | 4 | Feb 27, 2026 | 0001193125-26-085918 | View |
| Feb 27, 2026 | 8-K | Feb 26, 2026 | 0001193125-26-083227 | View |
| Feb 26, 2026 | 8-K | Feb 26, 2026 | 0001193125-26-077105 | View |
| Feb 23, 2026 | 8-K | Feb 23, 2026 | 0001193125-26-062537 | View |
| Feb 03, 2026 | 8-K | Feb 02, 2026 | 0001193125-26-035914 | View |